1. Home
  2. TELO vs SRTS Comparison

TELO vs SRTS Comparison

Compare TELO & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • SRTS
  • Stock Information
  • Founded
  • TELO 2021
  • SRTS 2010
  • Country
  • TELO United States
  • SRTS United States
  • Employees
  • TELO N/A
  • SRTS N/A
  • Industry
  • TELO
  • SRTS Medical/Dental Instruments
  • Sector
  • TELO
  • SRTS Health Care
  • Exchange
  • TELO NYSE
  • SRTS Nasdaq
  • Market Cap
  • TELO 58.6M
  • SRTS 83.9M
  • IPO Year
  • TELO 2024
  • SRTS 2016
  • Fundamental
  • Price
  • TELO $1.27
  • SRTS $4.67
  • Analyst Decision
  • TELO
  • SRTS Strong Buy
  • Analyst Count
  • TELO 0
  • SRTS 3
  • Target Price
  • TELO N/A
  • SRTS $11.67
  • AVG Volume (30 Days)
  • TELO 456.1K
  • SRTS 56.4K
  • Earning Date
  • TELO 08-12-2025
  • SRTS 08-07-2025
  • Dividend Yield
  • TELO N/A
  • SRTS N/A
  • EPS Growth
  • TELO N/A
  • SRTS N/A
  • EPS
  • TELO N/A
  • SRTS 0.11
  • Revenue
  • TELO N/A
  • SRTS $39,488,000.00
  • Revenue This Year
  • TELO N/A
  • SRTS $4.33
  • Revenue Next Year
  • TELO N/A
  • SRTS $31.55
  • P/E Ratio
  • TELO N/A
  • SRTS $42.60
  • Revenue Growth
  • TELO N/A
  • SRTS 24.75
  • 52 Week Low
  • TELO $1.19
  • SRTS $4.01
  • 52 Week High
  • TELO $8.40
  • SRTS $9.33
  • Technical
  • Relative Strength Index (RSI)
  • TELO 24.88
  • SRTS 47.56
  • Support Level
  • TELO $1.65
  • SRTS $4.50
  • Resistance Level
  • TELO $1.81
  • SRTS $4.99
  • Average True Range (ATR)
  • TELO 0.16
  • SRTS 0.20
  • MACD
  • TELO -0.04
  • SRTS -0.02
  • Stochastic Oscillator
  • TELO 9.29
  • SRTS 33.54

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: